Published in Immunology on September 01, 1983
Mouse and human neutrophils induce anaphylaxis. J Clin Invest (2011) 2.21
Evidence for the role of platelet-activating factor in immune complex vasculitis in the rat. J Clin Invest (1989) 1.09
The binding of immune complexes to human red cells: complement requirements and fate of the RBC-bound IC after interaction with human phagocytic cells. Clin Exp Immunol (1986) 0.85
The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science (1953) 9.02
The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles. J Immunol (1971) 5.76
Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med (1972) 5.38
Stimulation of human neutrophils by soluble and insoluble immunoglobulin aggregates. Secretion of granule constituents and increased oxidation of glucose. J Clin Invest (1975) 3.17
Acute immune complex disease in rabbits. The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets. J Exp Med (1971) 2.92
[Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine]. C R Seances Acad Sci D (1979) 2.53
In vitro studies of immunologically induced secretion of mediators from cells and related phenomena. Adv Immunol (1973) 2.32
Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol (1979) 2.31
Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets. Br J Haematol (1970) 2.27
Structural analysis of purified platelet-activating factor by lipases. Nature (1977) 2.09
Human neutrophil-derived platelet activating factor. J Immunol (1980) 1.82
Competition for immune complexes by red cells in human blood. J Clin Lab Immunol (1982) 1.74
Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses. J Clin Invest (1973) 1.64
Studies on apyrases. Arch Biochem Biophys (1961) 1.64
Immune reactions of human blood platelets. I. A comparative study on the effects on platelets of heterologous antiplatet antiserum, antigen-antibody complexes, aggregated gammaglobulin and thrombin. Thromb Diath Haemorrh (1968) 1.33
Release of platelet-activating factor and histamine. I. Effect of immune complexes, complement and neutrophils on human and rabbit mastocytes and basophils. Immunology (1977) 1.25
Interaction of IgG and its fragments with red cells. Immunology (1967) 1.15
Studies on the mechanism of immunoglobulin binding to red cells. Immunology (1967) 1.05
Role of prostaglandin synthesis in rabbit platelet activation induced by basophil-derived platelet-activating factor. J Immunol (1978) 0.99
Platelet-activating factor (PAF) in experimentally-induced rabbit acute serum sickness: role of basophil-derived PAF in immune complex deposition. J Immunol (1982) 0.99
Demonstration of a C1q receptor on the surface of human endothelial cells. J Immunol (1981) 0.97
Generation and release of platelet-activating factor (PAF) from enriched preparations of rabbit basophils; failure of human basophils to release PAF. J Immunol (1980) 0.95
Mediators of immune complex-induced aggregation of polymorphonuclear neutrophils. I. C5a anaphylatoxin, neutrophil cationic proteins and their cleavage fragments. Int Arch Allergy Appl Immunol (1980) 0.88
Platelet aggregation and release of ATP after incubation with soluble immune complexes purified from the serum of diabetic patients. Diabetes (1981) 0.87
Polymorphonuclear leucocytes release a factor(s) that induces platelet aggregation and ATP release after interaction with insoluble and surface-fixed immune complexes. Clin Exp Immunol (1982) 0.84
Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem (1977) 5.09
Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet (1995) 4.77
A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med (1995) 4.21
Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care (1995) 1.99
Effect of diabetic control on retinopathy. Diabetes (1966) 1.84
Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J Lipid Res (2000) 1.77
Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides. Lancet (1979) 1.67
Musculoskeletal manifestations during simvastatin therapy. Br J Rheumatol (1993) 1.58
Influence on patient management of general practitioner direct access to radiological services. Br J Radiol (1987) 1.55
Pheochromocytoma and ileus. JAMA (1972) 1.54
Body mass index, waist circumference, waist-hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK. J Epidemiol Community Health (1997) 1.51
Another look at diagnostic pathways in children with urinary tract infection. Br Med J (Clin Res Ed) (1984) 1.51
Controlling type 2 diabetes: are the benefits worth the costs? JAMA (1997) 1.45
Too many cystograms in the investigation of urinary tract infection in children? Br J Urol (1983) 1.44
Induction and suppression of immunoglobulin synthesis in cultures of human lymphocytes: effects of pokeweed mitogen and Staphylococcus aureus Cowan I. J Immunol (1980) 1.42
Increased platelet aggregation in early diabetus mellitus. Ann Intern Med (1975) 1.40
Contrast medium reactions. Clin Radiol (1995) 1.39
Evaluation of diagnostic tests. Clin Radiol (1989) 1.38
Effect of renal disease on renal uptake and excretion of insulin in man. N Engl J Med (1970) 1.38
Initial screening of children with urinary tract infections: is plain film radiography and ultrasonography enough? Br Med J (Clin Res Ed) (1984) 1.37
Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation. J Exp Med (1988) 1.34
Needling renal cysts and tumours: cytology and radiology. Br Med J (1975) 1.30
New method for obtaining IgA-specific protease. J Immunol Methods (1977) 1.30
Immunological and microbiological factors in the pathogenesis of atherosclerosis. Clin Immunol Immunopathol (1985) 1.29
Serum high density lipoprotein in diabetic patients. Diabetologia (1977) 1.28
Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care (2000) 1.28
Altered platelet function in diabetes mellitus. Diabetes (1976) 1.24
Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med (1981) 1.20
Lymphography and pelvic lymphadenectomy in carcinoma of the prostate. Br J Urol (1976) 1.20
The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia (2004) 1.18
Effects of therapeutically useful thiols (DL-penicillamine and alpha-mercaptopropionylglycine) on immunoglobulins. Clin Exp Immunol (1970) 1.14
Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus. Clin Immunol (1999) 1.14
Disseminated intravascular coagulation in diabetes mellitus, with reference to the role of increased platelet aggregation. Diabetes (1972) 1.13
Papain sensitivity of heavy chain sub-classes in normal human IgG and localizaton of antigenic determinants for the sub-classes. Immunochemistry (1971) 1.12
Diminished insulin response to hyperglycemia in prediabetes and diabetes. Diabetes (1967) 1.10
Isolation of soluble immune complexes by affinity chromatography using staphylococcal protein A--Sepharose as substrate. J Immunol Methods (1977) 1.10
Science in radiology. Lancet (1978) 1.09
Increased platelet aggregation in diabetes mellitus. J Lab Clin Med (1972) 1.08
Selective transport of an oligomeric IgA into canine saliva. Immunol Commun (1977) 1.07
Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy. Diabetologia (2002) 1.07
Gonadotropin secretion from a bronchogenic carcinoma. Demonstration by radioimmunoassay. N Engl J Med (1967) 1.07
Isolation and characterization of human antioxidized LDL autoantibodies. Arterioscler Thromb Vasc Biol (1996) 1.06
The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor. Atherosclerosis (1997) 1.06
Unexpected mobility of human lambda chains in sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Immunochemistry (1974) 1.06
Heavy chain typing in IgG monoclonal gammopathies with special reference to cases of serum hyperviscosity and cryoglobulinaemia. Clin Exp Immunol (1971) 1.05
Dental endosseous implant assessments in a type 2 diabetic population: a prospective study. Int J Oral Maxillofac Implants (2001) 1.05
Polyclonal activation of human peripheral blood B lymphocytes by formaldehyde-fixed Salmonella paratyphi B. I. Immunoglobulin production without DNA synthesis. J Exp Med (1981) 1.05
Distribution of heavy chain sub-classes of immunoglobulin G in normal IgG and residual IgG from hypogamma-globulinaemic sera. Clin Exp Immunol (1970) 1.04
The management of renal masses. Clin Radiol (1971) 1.04
High glucose-boosted inflammatory responses to lipopolysaccharide are suppressed by statin. J Periodontal Res (2007) 1.04
Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates. Diabetes Care (1986) 1.03
Evaluation of IgM, IgG, IgA, IgD, and IgE secretion by human peripheral blood lymphocytes in cultures stimulated with pokeweed mitogen and Staphylococcus aureus Cowan I. Cell Immunol (1980) 1.02
A quantitative immunofluorescence test for the detection of anti-Candida antibodies. J Immunol Methods (1980) 1.01
A family study of vesicoureteric reflux. J Med Genet (1978) 1.01
Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care (1998) 0.99
IgG heavy chain sub-classes in mixed cryoglobulins. Immunology (1972) 0.99
Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia (1982) 0.99
Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes. Diabetes (2000) 0.99
Renal masses and ultrasound. Br Med J (1975) 0.98
Measurement of salivary lysozyme. J Dent Res (1978) 0.98
Antegrade pyelography: a further look at an old technique. Br J Radiol (1972) 0.97
Computed tomographic observations in periaortitis: a hypothesis. Clin Radiol (1984) 0.96
Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein. Influences of degree of oxidation and location of oxidized LDL. Atherosclerosis (2001) 0.96
Soluble immune complexes in patients with diabetes mellitus: detection and pathological significance. Diabetologia (1981) 0.96
Differential binding of IgA proteins of different subclasses and allotypes to Staphylococcal protein A. Z Immunitatsforsch Immunobiol (1977) 0.96
Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int J Clin Lab Res (1993) 0.96
Immunological function in post-traumatic splenosis. Clin Immunol Immunopathol (1995) 0.96
Ultrasound assessment of residual urine in children. Br J Urol (1975) 0.95
Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes (1999) 0.95
Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls. Clin Immunol Immunopathol (1997) 0.95
Transport of oligomeric IgA of systemic origin into external secretions. Adv Exp Med Biol (1978) 0.95
Nephelometric detection of soluble immune complexes: methodology and clinical applications. Int Arch Allergy Appl Immunol (1979) 0.95
Immunoglobulin quantitation and enumeration of immunoglobulin-producing cells: comparison of two index of B-cell activation. Scand J Immunol (1980) 0.94
Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages. Arterioscler Thromb Vasc Biol (1999) 0.94
Fc-gamma receptor cross-linking by immune complexes induces matrix metalloproteinase-1 in U937 cells via mitogen-activated protein kinase. Arterioscler Thromb Vasc Biol (2000) 0.94
Electron microscopy of human and mouse myeloma serum IgA. J Mol Biol (1971) 0.94
Spina bifida occulta: lesion or anomaly? Clin Radiol (1985) 0.93
Nephelometric method for determination of rheumatoid factor. J Immunol Methods (1978) 0.93
The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA. Atherosclerosis (2000) 0.93
Placental transfer of human IgG subclasses. Clin Exp Immunol (1972) 0.93
Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study. Diabetes (1983) 0.93
Antibodies to Candida albicans in IgA-deficient humans. J Infect Dis (1977) 0.93
Upper urinary tract obstruction: pressure/flow studies in children. Br J Urol (1976) 0.92
Demonstration of molecular size differences between closely related antigens by a simple gel diffusion tes. Experientia (1969) 0.92
Differential sensitivity of IgA proteins of different subclasses and allotypes to reduction of disulfide bonds and digestion by streptococcal protease. Immunochemistry (1978) 0.92
Isolation and characterization of soluble insulin-anti-insulin immune complexes formed in vitro and in vivo in sera from patients with diabetes mellitus. Clin Exp Immunol (1980) 0.92
Expression of myogenic regulatory factors during the development of mouse tongue striated muscle. Arch Oral Biol (2000) 0.92